From: Association between sleep quality with maternal and neonatal outcomes during the covid-19 pandemic
Variable | No sleep disorders group n = 99 Mean ± SD | PSQI Correlation coefficient | P-value | Sleep disorders group n = 99 Mean ± SD | PSQI Correlation coefficient | P-value |
---|---|---|---|---|---|---|
FBS 24–28 week (mg/dl) | 80.21 ± 7.39 | -0.04 b | 0.67 | 93.68 ± 7.71 | 0.26 a | 0. 47 |
FBS 34–36 week (mg/dl) | 79.66 ± 8.85 | 0.03 a | 0.42 | 95.86 ± 10.11 | 0.33 a | 0.001 * |
CDA | 7.39 ± 5.73 | 0.01 a | 0.27 | 11.91 ± 9.20 | 0.35 b | 0.001* |
LFPL (min) | 156.25 ± 64.31 | 0.47 a | 0.78 | 173.21 ± 78.50 | 0.016 a | 0.89 |
LSPL (min) | 22.92 ± 11.91 | 0.14 b | 0.41 | 25.00 ± 13.15 | 0.15 a | 0.35 |
Birth Weight (g) | 3318.33 ± 47.96 | 0.30 a | 0.76 | 3270.11 ± 41.73 | 0.13 a | 0.18 |
Apgar 1st min | 8.77 ± 0.47 | -0.18 b | 0.06 | 8.86 ± 0.35 | 0.033 b | 0. 74 |
Apgar 5th min | 9.95 ± 0.26 | -0.05 b | 0.96 | 9.98 ± 0.14 | 0.082 b | 0.39 |